Cargando…

2730. Clinically significant cytomegalovirus infection in patients with lymphoma and no prior cellular therapy

BACKGROUND: Reactivation of cytomegalovirus (CMV) is commonly reported in lymphoma patients who undergo cellular therapy, with often poor outcomes. The risk for CMV reactivation in patients with lymphoma prior to cellular therapy is not well understood. As new alternative immunosuppressive therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zubovskaia, Anna, Khawaja, Fareed, Chemaly, Roy F, Primeaux, Brian, Waleed, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679170/ http://dx.doi.org/10.1093/ofid/ofad500.2341

Ejemplares similares

1538. High Mortality of Cytomegalovirus (CMV) Pneumonia in Hematopietic Cell Transplant Recipients
por: Batista, Marjorie, et al.
Publicado: (2018)

2730. Estimating Deaths Attributable to Influenza Mortality Using Traditional and Novel Forecasting Methods
por: McConeghy, Kevin, et al.
Publicado: (2019)

2798. Respiratory Viral Infections in Patients with Lymphoma and Multiple Myeloma: Risk Factors Associated with Progression to Lower Respiratory Tract Infection and Mortality
por: Martinez, Daniel De La Rosa, et al.
Publicado: (2019)

2681. Outcomes Related to Respiratory Viral Infections in Cancer Patients on PD-1 Inhibitors
por: Khawaja, Fareed, et al.
Publicado: (2019)

568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
por: Khawaja, Fareed, et al.
Publicado: (2020)

1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes
por: Febres-Aldana, Anthony J, et al.
Publicado: (2023)

15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies
por: Angelidakis, Georgios, et al.
Publicado: (2021)

922. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis
por: Spallone, Amy, et al.
Publicado: (2021)

1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
por: Khawaja, Fareed, et al.
Publicado: (2018)

Bobine de film de 300 metres, dessin no2730 DD, fiche technique
por: Chanel, G
Publicado: (1968)

Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
por: Khawaja, Fareed, et al.
Publicado: (2019)

Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?
por: Khawaja, Fareed, et al.
Publicado: (2022)

The Modulation of SCO2730/31 Copper Chaperone/Transporter Orthologue Expression Enhances Secondary Metabolism in Streptomycetes
por: González-Quiñónez, Nathaly, et al.
Publicado: (2021)

2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
por: Daher, Marilyne, et al.
Publicado: (2022)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti‐seizure medication
por: Fukushima, Kazuyuki, et al.
Publicado: (2023)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
por: Sassine, Joseph, et al.
Publicado: (2020)

735. Bacteriophage Therapy Improves Survival of Galleria mellonella Larvae Injected with Vancomycin-Resistant Enterococcus faecium
por: El Haddad, Lynn, et al.
Publicado: (2019)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

1914. Characteristics of Hospital Onset SARS Cov-2 Infections Before and After the Emergence of The Highly Transmissible Variant B.1.1.529 In a Comprehensive Cancer Center
por: Dib, Rita Wilson, et al.
Publicado: (2022)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

1730. Outcomes of Patients With Detectable Cytomegalovirus (CMV) DNA at Randomization in the Double-blind, Placebo-Controlled Phase 3 Trial of Letermovir (LET) Prophylaxis for CMV-Seropositive Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients
por: Marty, Francisco M, et al.
Publicado: (2018)

736. The Use of Bacteriophages to Inhibit Different Strains of Vancomycin-Resistant or Susceptible Enterococci
por: El Haddad, Lynn, et al.
Publicado: (2019)

Significance of Prior Culture History for Predicting Urinary Tract Infection Caused by Multi-drug Resistant Enterobacteriaceae
por: Bohan, Jefferson, et al.
Publicado: (2017)

Prevention of Cellular Suicide by Cytomegaloviruses
por: Fliss, Patricia M., et al.
Publicado: (2012)

2331. Seroprevalence of Cytomegalovirus in Pregnant Women and Birth Prevalence of Congenital Cytomegalovirus Infection in Henan Province, China
por: Huang, Yue, et al.
Publicado: (2019)

Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant
por: Shigle, Terri Lynn, et al.
Publicado: (2020)

Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology
por: Khawaja, Fareed, et al.
Publicado: (2023)

The Successful Recovery of Bacteriophages with Activity against Vancomycin-Resistant Enterococci (VRE) from Stool Samples of Hematopoietic Cell Transplant (HCT) Recipients
por: El Haddad, Lynn, et al.
Publicado: (2017)

How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
por: El Chaer, Firas, et al.
Publicado: (2022)

Abstract: Outcomes Following Breast Reconstruction in Patients with Prior Mantle Radiation for Treatment of Hodgkin’s Lymphoma
por: Chun, Yoon S., et al.
Publicado: (2017)

Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy
por: Landi, Daniel, et al.
Publicado: (2014)

Cytomegalovirus retinitis mimicking intraocular lymphoma
por: Gooi, Patrick, et al.
Publicado: (2008)

Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center
por: Ariza-Heredia, Ella J., et al.
Publicado: (2020)

2510. Epidemiological Change of Cytomegalovirus Diseases in the Developed Country With High Cytomegalovirus–Seropositive Rate: Nationwide, Whole Population-Based Study
por: Yoo, Seul Gi, et al.
Publicado: (2018)

Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention
por: Wilson Dib, Rita, et al.
Publicado: (2023)

355. Invasive Pulmonary Aspergillosis (IPA) Complicating Respiratory Viral Infections in Patients With Hematological Malignancies
por: Magira, Eleni, et al.
Publicado: (2018)

526. Significant Reduction of Hospital Onset Carbapenem-Resistant Enterobacteriaceae Utilizing Infection Prevention Strategies: It takes a Village!
por: Alexander, Kinta, et al.
Publicado: (2019)

1143. Late-Onset Hearing Loss and Antiviral Therapy for Congenital Cytomegalovirus Infection
por: Medoro, Alexandra K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ht9dj4se6iioe4mmvnlnivi1m7